Target-Therapie: Mechanismen
allgemeines
Target-Therapie: Mechanismen | |||
allgemeines | |||
| Target | Mechanismus | Beispiel | |
| EGFR, Epidermal Growth Factor Receptor | Inhibitor | Cetuximab (Erbitux) | |
| Her2/neu | Inhibitor | Trastuzumab (Herceptin) | |
| TK, Thyrosin-Kinasen | Inhibitor | Imatinib (Glivec) | |
| Angiogenese | VEGFR - Hemmer | Bevacizumab (Avastin) | |
| Proteasom | Inhibitor | Bortezomib (Velcade) | |
| PARP | Inhibitor | AZD2281 | |
| MEK1, MEK2 | Inhibitor | AZD6244 | |
| |||
Impressum .....................................................................................Zuletzt geändert am 27.01.2009 17:44